On May 2, 2022, Abbott Laboratories announced that at its annual general meeting of shareholder held on April 29, 2022, the shareholders rejected a shareholder proposal to lower the ownership threshold for calling special meetings of shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 USD | +0.63% | +0.23% | -2.31% |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
Apr. 26 | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B | |
-1.93% | 24.52B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Declaration of Voting Results by Abbott Laboratories